Finally, this review specifically compiled evidence related to vascular complications; however, other conditions closely associated with T2D—such as dyslipidemia, Alzheimer’s disease, and diabetic neuropathy—were excluded from this review despite resistin’s potential involvement in their pathophysiology. This evidence concerns the gene RETN and metabolic syndrome.